Efficacy and Safety of Vedolizumab with Glucocorticoids vs Infliximabin Severe Ulcerative Colitis: A Retrospective Study

Efficacy and Safety of Vedolizumab with Glucocorticoids vs Infliximabin Severe Ulcerative Colitis: A Retrospective Study

Chenfei Zhang,1 Xiaoling Huang,1 Mailidan Maimaitiniyazi,1 Tingwei Zhou2 1Xinjiang Uygur Autonomous Region People’s Hospital, Urumqi, Xinjiang, People’s Republic of China; 2Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of ChinaCorrespondence: Xiaoling Huang, Email Huangxia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhang C, Huang X, Maimaitiniyazi M, Zhou T
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-06-01
Series:	International Journal of General Medicine
Subjects:	Ulcerative Colitis，Vedolizumab，Glucocorticoid ，Infliximab，efficacy
Online Access:	https://www.dovepress.com/efficacy-and-safety-of-vedolizumab-with-glucocorticoids-vs-infliximabi-peer-reviewed-fulltext-article-IJGM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China
by: Hao Zhang, et al.
Published: (2025-07-01)

Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
by: Kei Nomura, et al.
Published: (2024-09-01)

Vedolizumab–steroid combination therapy improves long-term prognosis in patients with ulcerative colitis
by: Yosuke Yamada, et al.
Published: (2025-04-01)

Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis
by: Maha Alghamdi, et al.
Published: (2024-11-01)

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group
by: Nahla Azzam, et al.
Published: (2025-01-01)

The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab
by: Jing Yan, et al.
Published: (2025-03-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
by: E. A. Pyadushkina
Published: (2017-05-01)

Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
by: Hironobu Takedomi, et al.
Published: (2025-01-01)

Predictive Value of Albumin to Fibrinogen Ratio and CALLY Index for Diagnosis of Ulcerative Colitis and Mucosal Healing After Vedolizumab Treatment
by: Su K, et al.
Published: (2025-01-01)

Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects
by: Yibing Hu, et al.
Published: (2024-12-01)

Colonic Lung Cancer Metastasis in Vedolizumab-Treated Immune Checkpoint Inhibitor Colitis
by: Sean S. Davis, et al.
Published: (2020-07-01)

Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
by: Maria I. Timanovskaia, et al.
Published: (2025-01-01)

Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis
by: Li Yafang, et al.
Published: (2025-03-01)

Vedolizumab en tratamiento de colitis ulcerativa refractaria asociada con psoriasis: reporte de caso
by: Gabriel Alonso Mosquera-Klinger, et al.
Published: (2019-04-01)

The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats
by: Alexandra Menni, et al.
Published: (2025-04-01)

Case Presentation: a Facial Ulceration in a Patient with Ulcerative Colitis
by: Andreea GHIDERSA, et al.
Published: (2020-09-01)

How We Can Personalize the Infliximab Use in Ulcerative Patients
by: Mohammed Hussien Ahmed, et al.
Published: (2025-06-01)

Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis
by: Gerolamo Bevivino, et al.
Published: (2025-03-01)

Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials
by: Min Zhang, et al.
Published: (2025-07-01)

Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review
by: Vaidota Malinauskiene, et al.
Published: (2025-04-01)

High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia
by: Hanin Aljohani, et al.
Published: (2025-02-01)

Acute severe ulcerative colitis: using JAK-STAT inhibitors for improved clinical outcomes
by: Shruthi Karthikeyan, et al.
Published: (2024-11-01)

TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2023-11-01)

Clear Cell Renal Carcinoma in an Ulcerative Colitis Patient Under Short-Term Immunosuppressive Therapy: A Case Report
by: Raffaele Pellegrino, et al.
Published: (2025-04-01)

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis
by: Wenkai Zhang, et al.
Published: (2025-01-01)

The Use of Tissue Concentrations of Biological and Small-Molecule Therapies in Clinical Studies of Inflammatory Bowel Diseases
by: Ahmed B. Bayoumy, et al.
Published: (2024-11-01)

Comparative Efficacy of Different Targeted Therapies in Patients With Moderate‐to‐Severe Ulcerative Colitis: Systematic Review/Network Meta‐Analysis and Mechanistic Overview
by: Youran Dai, et al.
Published: (2025-06-01)

Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
by: Raffaele Pellegrino, et al.
Published: (2025-02-01)

Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
by: Şükrü Çekiç, et al.
Published: (2019-12-01)

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)

Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01)

Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
by: Jesus K. Yamamoto-Furusho, et al.
Published: (2025-01-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2020-01-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2019-01-01)

Is Infection Associated With Ulcerative Colitis Activity?
by: Ayoung Lee, et al.
Published: (2024-03-01)

Application of morphological criteria for definition of management approach for child with ulcerative colitis
by: E. N. Fedulova, et al.
Published: (2012-07-01)

Association of oral manifestations with severity of the disease in ulcerative colitis patients
by: Nikta Taghizadeh Tabarsi, et al.
Published: (2024-10-01)

Histologic healing and clinical outcomes in ulcerative colitis
by: Raymond Fueng-Hin Liang, et al.
Published: (2025-04-01)

Results of the microbiota assessment in experimental ulcerative colitis
by: A. D. Kim, et al.
Published: (2021-04-01)